Amy
L. DeMarco
B.A. Colgate University, 2005
2nd
Year Medical Student
Department:
Medicine
Graduate Program: Will be Molecular & Cellular
Pharmacology
Advisor:
Holly Colognato, Ph.D.
Abstract
(undergraduate):
Advisor:
Dr. Stephen Dewey, Medical Department, Brookhaven National
Laboratory
Title: Racemic
gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement
of conditioned place preference
DeMarco A, Dalal RM, Pai
J, Aquilina SD, Mullapudi U, Hammel C, Kothari SK, Kahanda M, Liebling
CN, Patel V, Schiffer WK, Brodie JD, Dewey SL.
Medical Department, Brookhaven National Laboratory, Upton, New York
11973.
Preventing
relapse poses a significant challenge to the successful management of
methamphetamine (METH) dependence. Although no effective medication
currently exists for its treatment, racemic gamma vinyl-GABA (R,S-GVG,
vigabatrin) shows enormous potential as it blocks both the neurochemical
and behavioral effects of a variety of drugs, including METH, heroin,
morphine, ethanol, nicotine, and cocaine. Using the reinstatement of
a conditioned place preference (CPP) as an animal model of relapse,
the present study specifically investigated the ability of an acute
dose of R,S-GVG to block METH-triggered reinstatement of a METH-induced
CPP. Animals acquired a METH CPP following a 20-day-period of conditioning,
in which they received 10 pairings of alternating METH and saline injections.
During conditioning, rats were assigned to one of four METH dosage groups:
1.0, 2.5, 5.0, or 10.0 mg/kg (i.p., n = 8/group). Animals in all dosage
groups demonstrated a robust and consistent CPP. This CPP was subsequently
extinguished in each dosage group with repeated saline administration.
Upon extinction, all groups reinstated following an acute METH challenge.
On the following day, an acute dose of R,S-GVG (300 mg/kg, i.p.) was
administered 2.5 h prior to an identical METH challenge. R,S-GVG blocked
METH-triggered reinstatement in all four groups. Given that drug re-exposure
may potentiate relapse to drug-seeking behavior, the ability of R,S-GVG
to block METH-triggered reinstatement offers further support for its
use in the successful management of METH dependence. Synapse 63:87-94,
2009. (c) 2008 Wiley-Liss, Inc.
Publications:
(pre-MSTP
publications indicated with an *)
*DeMarco
A, Dalal RM, Kahanda M, Mullapudi U, Pai J, Hammel C, Liebling
CN, Patel V, Brodie JD, Schiffer WK, Dewey SL, Aquilina SD. (2008).
Subchronic racemic gamma vinyl-GABA produces weight loss in Sprague
Dawley and Zucker fatty rats. Synapse. Nov;62(11):870-2.
*DeMarco
A, Dalal RM, Pai J, Aquilina SD, Mullapudi U, Hammel C, Kothari
SK, Kahanda M, Liebling CN, Patel V, Schiffer WK, Brodie JD, Dewey SL.
(2009). Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered
reinstatement of conditioned place preference. Synapse. Feb;63(2):87-94.